Search company, investor...
Medpace company logo

Medpace

medpace.com

Founded Year

1992

Stage

IPO | IPO

Date of IPO

8/11/2016

Market Cap

7.13B

Stock Price

239.52

About Medpace

Medpace is a global full-service clinical research organization providing Phase I-IV core development services for drug, biologic, and device programs. With medical and regulatory expertise in multiple therapeutic specialties providing drug development services.

Headquarters Location

5375 Medpace Way

Cincinnati, Ohio, 45227,

United States

513-579-9911

Missing: Medpace's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Medpace's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Medpace News

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 13, 2023

Jan 4, 2023

01/04/2023 | 04:07pm EST Message : *Required fields Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2022 financial results after the market close on Monday, February 13, 2023. The Company will host a conference call the following morning, Tuesday, February 14, 2023, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link . While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call. To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com . The webcast replay of the call will be available at the same site approximately one hour after the end of the call. A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call. About Medpace Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,000 people across 40 countries as of September 30, 2022. View source version on businesswire.com: https://www.businesswire.com/news/home/20230104005863/en/ © Business Wire 2023

Medpace Frequently Asked Questions (FAQ)

  • When was Medpace founded?

    Medpace was founded in 1992.

  • Where is Medpace's headquarters?

    Medpace's headquarters is located at 5375 Medpace Way, Cincinnati.

  • What is Medpace's latest funding round?

    Medpace's latest funding round is IPO.

  • Who are the investors of Medpace?

    Investors of Medpace include Cinven and CCMP Capital Advisors.

  • Who are Medpace's competitors?

    Competitors of Medpace include VivoSense.

Compare Medpace to Competitors

Pieces Technologies Logo
Pieces Technologies

Pieces Technologies builds software that interprets patient data in real-time, that changes points into warning tools that can save lives and strengthen communities inside and outside of hospital walls.

BioSerenity Logo
BioSerenity

BioSerenity develops wearable medical devices and digital point-of-care solutions, as well as electronic patient-reported outcome (ePRO), internet of things and cloud technologies.

MobileODT Logo
MobileODT

MobileODT enables mobile phones to detect cancer, providing the billions of people around the world who have access to mobile phone but do not have access to a physician who can provide a life saving diagnosis. The company's technology is not limited to mobile phones, too: MobileOCT can transform any digital camera into a powerful epithelial cancer discerning device. Its first focus is cervical cancer, the leading cause of cancer death for women in low resource settings - with a potential of 200M annual procedures.

Somatix Logo
Somatix

Somatix is a provider of wearable-enabled RPM (Remote Patient Monitoring) software platforms for healthcare. Its cost-effective solution uses patented gesture detection technology and machine learning algorithms to analyze user's gesture data in real-time. The algorithms remotely and passively detect physical and emotional indicators for generating insights on risk factors for adverse events, poor medical compliance, inactivity, falls, dehydration, and more.

Strados Labs Logo
Strados Labs

Strados Labs is a medical technology company developing smart sensor platforms that utilize machine learning and proprietary algorithms to detect and predict compounding conditions associated with serious, chronic respiratory diseases to improve the lives of patients globally. The company has developed a smart sensor platform for respiratory health, RESP™. The company was founded in 2016 and is based in Philadelphia, Pennsylvania.

Vector Remote Care Logo
Vector Remote Care

Vector Remote Care delivers accurate remote patient monitoring to cardiac clinics to reduce risk and improve patient outcomes. Its complete cardiac digital health software makes it simple for care teams to accurately capture, manage, analyze, and act on remote cardiac data. By taking the hard work out of remote cardiac monitoring, Vector’s technology enables companies to optimize their remote monitoring workflow and accelerate their digital health transformation.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.